AMI | Other CVE | p-value | |
Patients n | 21 | 107 | |
Demographics | |||
Females | 12 (57) | 55 (51) | 0.630 |
Age years | 79 (72–85) | 83 (75–88) | 0.258 |
Severity on admission | |||
PSI risk class V | 17 (81) | 53 (50) | 0.007 |
Severe sepsis | 15 (71) | 43 (40) | 0.009 |
Comorbidities | |||
Active neoplastic disease | 5 (24) | 14 (13) | 0.206 |
Chronic obstructive pulmonary disease | 9 (43) | 35 (33) | 0.371 |
Diabetes mellitus | 4 (19) | 25 (23) | 0.666 |
Prior cerebrovascular accident | 10 (48) | 33 (31) | 0.137 |
Liver disease | 5 (24) | 1 (0.9) | <0.001 |
Neurological diseases | 7 (33) | 33 (31) | 0.822 |
Renal disease | 2 (9.5) | 10 (9.3) | 0.980 |
Chronic renal failure | 7 (33) | 13 (12) | 0.015 |
Immunosuppression# | 6 (29) | 14 (13) | 0.074 |
Family history of coronary artery disease | 6 (29) | 18 (17) | 0.207 |
Essential arterial hypertension | 11 (52) | 63 (59) | 0.581 |
Congestive heart failure | 9 (43) | 33 (31) | 0.284 |
Coronary artery disease | 8 (38) | 29 (27) | 0.310 |
Prior acute myocardial infarction | 4 (19) | 19 (18) | 0.888 |
Atrial fibrillation | 6 (29) | 27 (25) | 0.749 |
Hyperlipidaemia | 7 (33) | 19 (18) | 0.105 |
Medications before admission | |||
Aspirin | 10 (48) | 41 (38) | 0.426 |
β-blockers | 6 (29) | 26 (24) | 0.679 |
ACE inhibitors | 6 (29) | 36 (34) | 0.651 |
Warfarin | 2 (9.5) | 5 (4.7) | 0.371 |
Heparin | 0 (0) | 5 (4.7) | 0.312 |
Antiplatelets | 1 (4.8) | 15 (14) | 0.241 |
Statins | 4 (19) | 10 (10) | 0.253 |
Clinical and laboratory data on admission | |||
Platelets >450 000 per μL | 4 (20) | 4 (3.8) | 0.006 |
Lactate dehydrogenase mg·dL−1 | 510 (389–725) | 391 (321–502) | 0.036 |
Triglycerides mg·dL−1 | 108 (93–157) | 94 (72–117) | 0.041 |
Glucose mg·dL−1 | 168 (132–225) | 128 (109–183) | 0.033 |
Cholesterol mg·dL−1 mean±sd | 178±72 | 148±35 | 0.034 |
Data are presented as n (%) or median (interquartile range), unless otherwise stated. AMI: acute myocardial infarction; PSI: Pneumonia Severity Index; ACE: angiotensin-converting enzyme. #: presence of at least one of active cancer, asplenia or HIV infection.